November 20, 2014 : Episode 1

Video

Latest News & Insight: November 20, 2014

Related Videos
Thomas Westbrook, MD, assistant professor, Department of Internal Medicine, Rush University
Stephanie L. Graff, MD
Stephanie L. Graff, MD
5 experts are featured in this series
Chandler Park, MD, FACP, genitourinary medical oncologist, Norton Cancer Institute
Alan Tan, MD, genitourinary oncology and melanoma specialist, Vanderbilt-Ingram Cancer Center; associate professor, medicine, Division of Hematology Oncology, Vanderbilt University Medical Center
Bartosz Chmielowski, MD
Whitney Goldsberry, MD
Laura A. Huppert, MD
Related Content
Bradley McGregor, MD
January 15th 2025

Nivolumab Plus Ipilimumab May Offer Efficacious Therapeutic Approach in Rare GU Cancers

MedNews Week
January 1st 2025

DESTINY-Breast06 Data Demonstrate the Role of T-DXd in HER2-Low and -Ultralow Breast Cancer: With Chandler Park, MD; and Guiseppe Curigliano, MD, PhD

Early-Stage CTCL | Image Credit: ©ReisMedia - stock.adobe.com
January 14th 2025

Continuous Synthetic Hypericin Generates Responses in Early-Stage Cutaneous T-Cell Lymphoma

Oncology Unplugged
November 6th 2024

Review Key Genitourinary Cancer Data From the 2024 ESMO Congress With Chandler Park, MD

Leuprolide Mesylate in Advanced Prostate Cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
January 13th 2025

PDUFA Date Set for 3-Month Variation of Leuprolide Mesylate in Advanced Prostate Cancer

Erica L. Mayer, MD, MPH
January 13th 2025

Neoadjuvant Niraparib Plus Dostarlimab Data Support Development of Non-Chemo Approaches in BRCA+, ER+ Breast Cancer